Results

Bayer Corporation

09/16/2021 | Press release | Distributed by Public on 09/16/2021 00:40

Latest Analyses of Vitrakvi® (larotrectinib) Support Consistently Meaningful Clinical Profile for Both Adult and Pediatric Patients with TRK Fusion Cancer